en million thalidomide pills had already been produced for distribution in the United States when it was first submitted to the FDA for approval. The morning sickness wonder drug had been approved for sale in Germany, Canada, and the UK, and the drug's distributors assumed that it would be no different in the United States. The answer they received was unexpected and firm: it needed more testing. It later came to light that thalidomide was causing...